Only biotechwith 2 Myron'son theleadershipteamWe willhaveexclusivityWe will openupinternationalsites forMino-Lok trialI/ONTAKwas thebest deal Iever madeI'm ashareholdermyselfAn actualiMSCupdateMino-WrapThere are noFDAapproveddrugs to treathemorrhoidsWe had aphase 2btrial with100%efficacyI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Not manycompaniesthis size with2 late stageassetsOur Halo-Lido trial willhave finalpatient byend of 2022I/Ontak isour leadassetWe haveenough cashto go wellinto 2023I/ONTAK'spotentialmarket is>$300mMino-Lokpotentialmarket>$1BWe intendto submita BLA in2H 2022Insidersinvested$26.5mI won't diluteshareholdersWe expect tofinish theMino-Loktrial this yearMyron Holubiakand I founded aprivatecompany in2013The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Hemorrhoidsis a $2BmarketMino-Lokis our leadassetOnly biotechwith 2 Myron'son theleadershipteamWe willhaveexclusivityWe will openupinternationalsites forMino-Lok trialI/ONTAKwas thebest deal Iever madeI'm ashareholdermyselfAn actualiMSCupdateMino-WrapThere are noFDAapproveddrugs to treathemorrhoidsWe had aphase 2btrial with100%efficacyI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Not manycompaniesthis size with2 late stageassetsOur Halo-Lido trial willhave finalpatient byend of 2022I/Ontak isour leadassetWe haveenough cashto go wellinto 2023I/ONTAK'spotentialmarket is>$300mMino-Lokpotentialmarket>$1BWe intendto submita BLA in2H 2022Insidersinvested$26.5mI won't diluteshareholdersWe expect tofinish theMino-Loktrial this yearMyron Holubiakand I founded aprivatecompany in2013The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Hemorrhoidsis a $2BmarketMino-Lokis our leadasset

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
G
2
I
3
B
4
I
5
G
6
B
7
N
8
I
9
N
10
N
11
I
12
B
13
G
14
O
15
N
16
G
17
O
18
B
19
G
20
B
21
O
22
O
23
O
24
I
  1. G-Only biotech with 2 Myron's on the leadership team
  2. I-We will have exclusivity
  3. B-We will open up international sites for Mino-Lok trial
  4. I-I/ONTAK was the best deal I ever made
  5. G-I'm a shareholder myself
  6. B-An actual iMSC update
  7. N-Mino-Wrap
  8. I-There are no FDA approved drugs to treat hemorrhoids
  9. N-We had a phase 2b trial with 100% efficacy
  10. N-I/ONTAK was previously approved but taken off the market to improve manufacturing.
  11. I-Not many companies this size with 2 late stage assets
  12. B-Our Halo-Lido trial will have final patient by end of 2022
  13. G-I/Ontak is our lead asset
  14. O-We have enough cash to go well into 2023
  15. N-I/ONTAK's potential market is >$300m
  16. G-Mino-Lok potential market >$1B
  17. O-We intend to submit a BLA in 2H 2022
  18. B-Insiders invested $26.5m
  19. G-I won't dilute shareholders
  20. B-We expect to finish the Mino-Lok trial this year
  21. O-Myron Holubiak and I founded a private company in 2013
  22. O-The name Citius comes from the Olympic motto "Citius,Altius Forius"
  23. O-Hemorrhoids is a $2B market
  24. I-Mino-Lok is our lead asset